Bone scan

What it is

A bone scan is a nuclear medicine test that uses a small amount of radioactive tracer to show areas of increased bone activity. In most routine studies, images are taken about 2 to 4 hours after the tracer is injected, because that delay allows the tracer to circulate and collect in bone. Bone scintigraphy, radionuclide bone scan, and skeletal scintigraphy are different names for the same procedure.

The test does not show bone structure in the same way as a plain X-ray or CT. Instead, it highlights bone metabolism, especially areas where bone is being repaired, inflamed, infected, or affected by tumour. This is why a bone scan is considered highly sensitive for many bone problems, but it is not fully specific. A "hot spot" can be caused by cancer, but also by arthritis, fracture healing, infection, or other benign conditions.

In cancer care, bone scans are commonly used to look for spread of cancers such as prostate, breast, and some lung cancers to the skeleton. They may also be used for unexplained bone pain, suspected stress fracture, osteomyelitis, or evaluation of certain joint prosthesis problems. In India, bone scans are widely available at tertiary hospitals and nuclear medicine centres, usually using technetium-99m-labelled diphosphonate tracers.

Term	Meaning
Hot spot	Area of increased tracer uptake, often due to high bone turnover
Cold spot	Area of reduced uptake, seen in some lesions with poor blood flow or certain tumour patterns
Whole-body bone scan	Standard scan covering most or all of the skeleton
Three-phase bone scan	Adds early blood-flow and blood-pool images, often useful for infection or some pain syndromes

How it works

A bone scan works by using a radiotracer that is taken up more strongly in areas of active bone formation and blood flow. The most common tracers are technetium-99m-labelled phosphonate compounds, such as methylene diphosphonate. After injection into a vein, the tracer circulates in the bloodstream and binds to hydroxyapatite in bone, especially where osteoblastic activity is increased.

A gamma camera then detects the radiation emitted by the tracer and creates images of the skeleton. Areas with more uptake appear darker or brighter depending on the display format. Because many bone diseases increase local bone turnover, the scan can detect abnormalities before some changes become visible on standard radiographs.

There are a few common scan formats:

1. Delayed whole-body bone scan: the standard cancer-related study, usually performed a few hours after injection.
2. Three-phase bone scan: includes immediate blood-flow images, early soft-tissue images, and delayed bone images.
3. SPECT or SPECT/CT: adds cross-sectional imaging and, when combined with CT, can improve localisation and interpretation.

SPECT/CT is especially helpful when a planar bone scan shows an unclear focus, such as in the spine, ribs, pelvis, or around joints.

Evidence and uses

Bone scintigraphy has been a core skeletal imaging test for decades because it is very sensitive for detecting many disorders that change bone turnover. It is useful for both benign and malignant disease, but findings must be interpreted with the clinical picture and often with other imaging.

Common uses include:

• Detecting bone metastases, especially from prostate and breast cancer.
• Investigating unexplained bone pain.
• Finding stress fractures or occult fractures not seen on early X-rays.
• Evaluating suspected bone infection or some prosthetic joint complications.
• Assessing disorders such as Paget disease.

For cancer, a bone scan is often used when there is a meaningful chance of skeletal spread or when symptoms suggest bone involvement. It is particularly good at detecting osteoblastic response, which is common in prostate cancer metastases. However, some cancers or lesions that are mainly lytic may be less conspicuous, and PET/CT, MRI, or CT may be preferred in some settings.

A key limitation is specificity. Increased uptake does not automatically mean cancer. Degenerative spine disease, old fractures, arthritis, recent surgery, and infection can all produce hot spots. This is why reports often recommend correlation with X-ray, CT, MRI, PET/CT, blood tests, or prior imaging.

Bone scan findings are usually described as:

• Normal: expected symmetric tracer distribution.
• Focal increased uptake: one or more hot spots.
• Diffuse abnormal uptake: more widespread skeletal involvement.
• Equivocal: uncertain significance, needing further evaluation.

In oncology, bone scans remain useful and widely used, but newer imaging methods have changed practice in some cancers. For example, MRI is often better for marrow disease and spinal cord risk, while PET-based imaging may be more accurate in selected tumour types.

Diagnosis / how it's measured

A bone scan is a procedure rather than a lab test. The result is based on image interpretation by a nuclear medicine physician or radiologist.

The usual steps are:

1. A small amount of radiotracer is injected into a vein.
2. The patient waits while the tracer distributes, commonly 2 to 4 hours for delayed images.
3. The patient lies still on a scanning table while a gamma camera records images.
4. Additional spot views or SPECT/CT may be done if needed.

Patients are often advised to drink water after the injection and to empty the bladder before imaging, because this can reduce background activity and improve image quality. The scan itself is painless, though lying still may be uncomfortable if there is significant bone pain.

Preparation is usually simple. Patients should tell the imaging team about pregnancy, possible pregnancy, breastfeeding, recent nuclear medicine tests, and any difficulty lying flat. Metal objects may need to be removed. In breastfeeding patients, advice may vary depending on the tracer and local protocol, so the nuclear medicine team should give specific instructions.

The radiation dose from a routine bone scan is generally considered low, but it is still an ionising radiation test. The benefit of the scan should outweigh the risk, especially in children and during pregnancy.

When to see a clinician

A clinician may recommend a bone scan if you have persistent unexplained bone pain, a suspected stress fracture with a normal X-ray, concern for bone infection, or a cancer that may have spread to bone. In cancer care, urgent review is important if bone pain is severe, worsening, or associated with weakness, numbness, difficulty walking, or loss of bladder or bowel control, because these can suggest spinal cord compression.

You should also contact your care team if you are pregnant, think you may be pregnant, or are breastfeeding before the test. If you have had a recent scan using another radioactive tracer, mention this because it can affect scheduling or interpretation.

After the scan, most people can return to normal activities. Seek medical advice if you develop new severe pain, fever, or symptoms that the scan was meant to investigate, because imaging results need to be interpreted in context and may not provide an immediate final diagnosis.

Limitations and open questions

Bone scans are highly sensitive, but they are not specific. A hot spot shows increased bone activity, not a diagnosis by itself. This is the main reason false-positive findings occur.

The test is also less informative for some lesions that do not trigger much osteoblastic response. Early marrow disease may be better seen on MRI, and some cancers are better assessed with PET/CT or targeted molecular imaging. Availability, cost, and local expertise influence which test is chosen.

Another limitation is that interpretation can be difficult after recent trauma, surgery, radiation therapy, or around prosthetic joints, because healing itself increases uptake. SPECT/CT has improved localisation and confidence in many of these situations, but it does not remove all uncertainty.

Current practice is moving toward more tailored imaging rather than one test for every patient. For many people, bone scintigraphy remains a useful, accessible whole-skeleton survey, but the best test depends on the clinical question, cancer type, and what other imaging has already shown.